Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Syros Pharmaceuticals Inc SYRS

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARa), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in... see more

Bullboard (NDAQ:SYRS)

View:
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Sep 05, 2024 11:47am

Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros

NEWS: $SYRS Bronstein, Gewirtz and Grossman, LLC Is Investigating Syros Pharmaceuticals, Inc. (SYRS) And Encourages Investors to ConnectNEW YORK CITY, NY / ACCESSWIRE / September 5, 2024 / Bronstein ...more  
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Aug 29, 2024 1:45pm

Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharma

Just In: $SYRS Bronstein, Gewirtz and Grossman, LLC Encourages Syros Pharmaceuticals, Inc. (SYRS) Stockholders to Inquire about Securities InvestigationNEW YORK CITY, NY / ACCESSWIRE / August 29, 2024 ...more  
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Aug 28, 2024 2:02pm

Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein,

NEWS: $SYRS Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsNEW YORK CITY, NY / ACCESSWIRE ...more  
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Aug 26, 2024 3:32pm

Bronstein, Gewirtz and Grossman, LLC Announces an Investigat

BREAKING NEWS: $SYRS Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Syros Pharmaceuticals, Inc. (SYRS) and Encourages Investors to Seek Compensation for Alleged WrongdoingsNEW ...more  
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 02, 2024 10:55am

Syros (NASDAQ:SYRS) Poised for Potential Breakthrough in Hem

https://beyondspx.com/2024/07/31/syros-nasdaqsyrs-poised-for-potential-breakthrough-in-hematologic-malignancies/
User Avatar Image
(280)
•••
  • whytestocksX
Post by whytestockson Jun 13, 2024 2:30pm

Syros to Host Webcast Event on Higher-Risk Myelodysplastic S

News; $SYRS Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities